title: A pharmaceutical company user's perspective on the potential of high content screening in drug discovery.
abstract: It is early to fully reflect on the state of the art in high content screening (HCS), because it is still a relatively new approach in drug discovery. Although the development of the first microscopes are a century old and the first confocal microscope is only 20 yr old, the fluorescent probes used within HCS along with the combination of robotic automation and integrated software technologies are quite new. HCS will require a few more years to fully demonstrate its potential power in drug discovery. Within the last year, however, one has seen this ever-expanding field lure participants in from all areas of science, introducing newer versions of instruments and reagents such that the combined efforts result in platforms and tools that meet many organizational goals in multiple ways. The potential of HCS today lies in its versatility. HCS can be used for primary screening, basic research, target identification, biomarkers, cytotoxicity, and helping to predict clinical outcomes. HCS is being applied to stem cells, patient cells, primary hepatocytes, and immortalized cultured cells. We have noted for individual specialized assays, there are multiple solutions just as there are for those standardized universally accepted assays. Whether we have needed to query cellular processes under live conditions or wanted to follow kinetically the course of a compound's effects on particular cellular reactions, we have been hampered by only a few limitations. This chapter offers a glimpse inside the use of HCS in our drug discovery environment.
authors.affiliation: Hoffmann-La Roche, Inc., Nutley, NJ, USA.
authors.forename: Ann F
authors.initials: AF
authors.lastname: Hoffman
authors.forename: Ralph J
authors.initials: RJ
authors.lastname: Garippa
mesh_terms: D000818:Animals; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004345:Drug Industry / Q000379:methods*; D006801:Humans; D015162:Micronucleus Tests; D021381:Protein Transport; D034741:RNA, Small Interfering; D043562:Receptors, G-Protein-Coupled / Q000032:analysis; D012984:Software; D046888:Tissue Array Analysis / Q000379:methods*; D014157:Transcription Factors / Q000378:metabolism
chemical_list: D034741:RNA, Small Interfering; D043562:Receptors, G-Protein-Coupled; D014157:Transcription Factors